Our medicines
We are a global biopharmaceutical company focused on helping to address the unmet medical needs of patients with serious diseases. In 2022, we invested $9.5 billion in R&D, which included the discovery and development of new medicines.
Report side effects or product quality complaints
Below is a list of our company's marketed products. Any linked documents and websites are intended only for U.S. residents 18 years or older, as the availability of medicines and the indications for which they are approved can vary with country and region.
ABECMA® (idecabtagene vicleucel)
ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
AUGTYRO™ (repotrectinib)
AZACTAM® (aztreonam for injection, USP)
BREYANZI® (lisocabtagene maraleucel)
BARACLUDE® (entecavir)
CAMZYOS® (mavacamten)
COBENFYTM (xanomeline and trospium chloride)
ELIQUIS® (apixaban)
EMPLICITI® (elotuzumab)
EVOTAZ® (atazanavir and cobicistat)
IDHIFA® (enasidenib)
INREBIC® (fedratinib)
ISTODAX® (romidepsin)
KENALOG®-10 (triamcinolone acetonide)
KENALOG® -40 (triamcinolone acetonide) and
KENALOG® -80 (triamcinolone acetonide)
KRAZATI® (adagrasib)
NULOJIX® (belatacept)
ONUREG® (azacitidine tablets)
OPDIVO® (nivolumab)
OPDUALAG™ (nivolumab and relatlimab-rmbw)
ORENCIA® (abatacept)
POMALYST® (pomalidomide)
REBLOZYL® (luspatercept-aamt)
REVLIMID® (lenalidomide)
REYATAZ® (atazanavir)
SOTYKTU™ (deucravacitinib)
SPRYCEL® (dasatinib)
THALOMID® (thalidomide)
VIDAZA® (azacitidine)
YERVOY® (ipilimumab)
ZEPOSIA® (ozanimod)
Legacy brands
DROXIA® (hydroxyurea)
HYDREA® (hydroxyurea)
Prescribing information
Please click below to see the full U.S. Prescribing Information, including Boxed WARNING and Medication Guide/Patient Information for:
| ABECMA® | Medication guide | Prescribing information |
| ABRAXANE® | Patient information | Prescribing information |
| BREYANZI® | Medication guide | Prescribing information |
| BARACLUDE® | Patient information | Prescribing information |
| CAMZYOS® | Prescribing information | |
| COBENFY(TM) | Patient information | Prescribing information |
| DROXIA® | Prescribing information | |
| ELIQUIS® | Medication guide | Prescribing information |
| IDHIFA® | Patient information | Prescribing information |
| INREBIC® | Patient information | Prescribing information |
| KRAZATI® | Patient information | Prescribing information |
| POMALYST® | Patient information | Prescribing information |
| REVLIMID® | Patient information | Prescribing information |
| THALOMID® | Patient information | Prescribing information |
| NULOJIX® | Medication guide | Prescribing information |
| YERVOY® | Medication guide | Prescribing information |